Last reviewed · How we verify
vitamin c 20% — Competitive Intelligence Brief
marketed
Vitamin / Antioxidant / Micronutrient
Nutritional supplementation / General health
Small molecule
Live · refreshed every 30 min
Target snapshot
vitamin c 20% (vitamin c 20%) — Kasr El Aini Hospital. Vitamin C (ascorbic acid) acts as a reducing agent and antioxidant, donating electrons to neutralize free radicals and support collagen synthesis and immune function.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| vitamin c 20% TARGET | vitamin c 20% | Kasr El Aini Hospital | marketed | Vitamin / Antioxidant / Micronutrient |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin / Antioxidant / Micronutrient class)
- Kasr El Aini Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- vitamin c 20% CI watch — RSS
- vitamin c 20% CI watch — Atom
- vitamin c 20% CI watch — JSON
- vitamin c 20% alone — RSS
- Whole Vitamin / Antioxidant / Micronutrient class — RSS
Cite this brief
Drug Landscape (2026). vitamin c 20% — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-c-20. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing